The injury of mitochondrial biosynthesis and antioxidant response aggravates the severity of NAFLD induced by HFD, while pharmacological stimulation of SIRT3 expression can improve mitochondrial function and reduce hepatic steatosis [140]. Here, SIRT3 is linked to metabolic dysfunction-associated steatotic liver disease.